Verastem, Inc. (VSTM)

Verastem, Inc. (VSTM) is a healthcare company (biotechnology) based in the United States. The share price is $7.53, down 2.21% on the day, which values the company at $948.89M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$7.53−2.21% today
Market value
$948.89M
Funk Score
30/100
Against its own history
Well above its usual priceusual price $5.03
200-week average
$6.958% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Verastem, Inc. in more detail

VSTM trades at -4.9× next year's expected earnings, 9.5× sales. Measured against its own history, the price is 50% above what its usual multiples would imply ($5.03) — well above its usual price. It sits 8% above its 200-week average of $6.95.

Over the last five fiscal years Verastem, Inc. has compounded revenue -19.0% a year. Its Funk Score is 30 out of 100 (financial strength 3.9, profitability 2.5, growth 5.6, value 0.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

1 of the superinvestors tracked here hold VSTM, including Julian and Felix Baker (0.0% of the portfolio).

Superinvestors holding VSTM

1 of the investors tracked here report a position in their latest 13F filing.

Verastem, Inc. (VSTM): questions and answers

What is Verastem, Inc.'s market cap?

Verastem, Inc. is valued at $948.89M at a share price of $7.53.

Is VSTM overvalued or undervalued?

Against its own history, VSTM is well above its usual price: the price is 50% above the $5.03 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is VSTM above its 200-week moving average?

Yes. VSTM is 8.4% above its 200-week average of $6.95. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Verastem, Inc. growing?

Over the last five fiscal years Verastem, Inc.'s revenue grew -19.0% a year.

Does VSTM pay a dividend?

Verastem, Inc. does not currently pay a regular dividend.

Which famous investors own VSTM?

In their latest quarterly filings, Julian and Felix Baker (0.0% of the portfolio) hold VSTM. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Verastem, Inc. (VSTM) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VSTM

Underlying data: Yahoo Finance; company filings with the SEC.